Woodford Patient Capital Trust has issued a statement emphasising the “long-term approach of the company," following the decision of its portfolio manager Woodford Investment Management to suspend withdrawals from the LF Woodford Equity Income Fund. It says its board notes the reaction of its share price and the prices of quoted portfolio companies in which WEIF is invested. The board is “pleased with the operational progress” of its portfolio companies, which it believes continue to have the potential to deliver “attractive returns”. Chairwoman Susan Searle says the board is “closely monitoring the situation,” engaging with shareholders and advisers and holding “regular dialogue” with the portfolio manager. It will “continue to keep shareholders updated as necessary”.
Woodford Patient Capital Trust Plc (WPCT.L) Announced an update for the recent developments at Woodford Investment Management Ltd. Following the events relating to LF Woodford Equity Income Fund (WEIF), the Board noted the reaction in the company's share price and the share prices of certain quoted portfolio companies in which WEIF is also invested. The company content with the operational progress of its portfolio companies, which the Board believes continue to have the potential to deliver attractive returns, in line with the long-term mandate of the company. The operational performance of these businesses is not impacted by recent events.
RNS Number: 5997 B Woodford Patient Capital Trust PLC 10 June 2019 10 June 2019. Woodford Patient Capital Trust plc. The Board of Woodford Patient Capital Trust plc notes the recent developments at Woodford Investment Management Ltd..
RNS Number: 2755 B Woodford Patient Capital Trust PLC 05 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3263 Z Woodford Patient Capital Trust PLC 16 May 2019 Woodford Patient Capital Trust plc Result of Annual General Meeting. The Company announces that at the Annual General Meeting held earlier today all resolutions set out in the Notice of AGM were passed by the requisite majority. RNS is approved by the Financial Conduct Authority to act as a...
RNS Number: 9208 X Woodford Patient Capital Trust PLC 02 May 2019 Woodford Patient Capital Trust plc. Following a positive reimbursement decision in the US for Inivata's maiden non-invasive blood cancer test and a successful $52.6 m fundraising in March, Inivata's valuation has this week been revised upwards by Link Fund Solutions Limited, WPCT's appointed...
RNS Number: 6455 X Woodford Patient Capital Trust PLC 01 May 2019 Woodford Patient Capital Trust PLC. Further to the Chairman's statement in the WPCT 2018 Annual Report, which announced that Alan Hodson will be stepping down from the Board in the summer, the Company can now confirm that he will step down as a non-executive Director of the Company at the Annual...
Portfolio update: Evofem raises $30 m from PDL BioPharma. LF Woodford Equity Income Fund portfolios, has entered into a securities purchase agreement to raise up to $80 million through a private placement of common stock from new and existing investors, including a strategic investment from NASDAQ-listed PDL BioPharma.. The investment is structured in two...
ReNeuron partners with China- based Fosun Pharma in deal worth up to £80 m. ReNeuron, a company in the Woodford Patient Capital Trust, has signed an exclusive agreement with Shanghai- based Fosun Pharma to fully fund the development, manufacture and commercialisation of its CTX and hRPC cell therapy programmes in China.. The partnership is worth up to £80 m and...
British fund manager Neil Woodford’s investment trust, Woodford Patient Capital Trust, reported a 6.9% increase in net asset value to 97.61p in 2018. Woodford said the portfolio's success stories were gradually beginning to account for a larger proportion of assets.
Woodford Patient Capital Trust Plc (WPCT.L) Announced, in its audited financial report for the year ended 31 December 2018, that its gain on investment stood at £55.75 million, compared to loss on investment of £12.36 million in the preceding year. The company’s earnings per share was 6.27p, compared to loss per share of 1.91p.
RNS Number: 2115 V Woodford Patient Capital Trust PLC 05 April 2019. Woodford Patient Capital Trust plc. Woodford Patient Capital Trust plc, announces the audited financial report for the year ended 31 December 2018..
RNS Number: 7049 U Woodford Patient Capital Trust PLC 01 April 2019 Woodford Patient Capital Trust PLC. In conformity with the provisions of the FCA's Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 31 March 2019, were as follows:. RNS is approved by the Financial...
RNS Number: 3844 U Woodford Patient Capital Trust PLC 28 March 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2159 T Woodford Patient Capital Trust PLC 18 March 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6353 S Woodford Patient Capital Trust PLC 12 March 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1868 S Woodford Patient Capital Trust PLC 07 March 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1735 S Woodford Patient Capital Trust PLC 07 March 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0920 S Woodford Patient Capital Trust PLC 06 March 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    908.64M

Company Profile

Investment Trust specialising in disruptive early-stage and early-growth companies, alongside some 'high conviction' mid and large-capitalisation ideas. It purchases stakes in companies with first-rate intellectual property, helping them to meet their growth potential through the provision of long-term capital. Managed by fund manager Neil Woodford, the fund believes it can offer lower correlation in risk to equity markets in general and the economy, which may offer diversification benefits, although outcomes can be more binary, with extremely attractive rewards for success but with failure entailing the risk of capital loss.

Classification

Market Indices-
Watchlist